{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:19:05Z","timestamp":1792725545558,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.urology.2022.08.035","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T02:04:50Z","timestamp":1663121090000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1281-5915","authenticated-orcid":false,"given":"Brandon S.","family":"Imber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lobaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gorovets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke R.G.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gewanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borys","family":"Mychalczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Zelefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.08.035_bib0001","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2022.08.035_bib0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2005.07.007","article-title":"Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794)","volume":"63","author":"Swanson","year":"2005","journal-title":"Int J Radiat Oncol Bio Phy."},{"key":"10.1016\/j.urology.2022.08.035_bib0003","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet North Am Ed."},{"key":"10.1016\/j.urology.2022.08.035_bib0004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96\u201302\/AUO AP 09\/95 trial","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur Urol."},{"key":"10.1016\/j.urology.2022.08.035_bib0005","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.ijrobp.2019.06.456","article-title":"A phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage radiotherapy following a radical prostatectomy: results of the TROG 08.03 and ANZUP \u201cRAVES\u201d trial","volume":"105","author":"Kneebone","year":"2019","journal-title":"Int J Radiat Oncol Bio Phy."},{"key":"10.1016\/j.urology.2022.08.035_bib0006","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): A randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.urology.2022.08.035_bib0007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.euo.2018.04.014","article-title":"Impact of biochemical failure after salvage radiation therapy on prostate cancer-specific mortality: competition between age and time to biochemical failure","volume":"1","author":"Jackson","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0008","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.2021202771","article-title":"Prostate-specific membrane antigen PET in prostate cancer","volume":"299","author":"Lawhn-Heath","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2022.08.035_bib0009","article-title":"The role of prostate-specific membrane antigen positron emission tomography\/magnetic resonance imaging in primary and recurrent prostate cancer: a systematic review of the literature","author":"Manfredi","year":"2021","journal-title":"Eur Urol Focus."},{"key":"10.1016\/j.urology.2022.08.035_bib0010","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.juro.2018.05.164","article-title":"A clinician's guide to next generation imaging in patients with advanced prostate cancer (RADAR III)","volume":"201","author":"Crawford","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.035_bib0011","doi-asserted-by":"crossref","unstructured":"Trabulsi EJ, Rumble RB, Jadvar H, et al. Optimum imaging strategies for advanced prostate cancer: ASCO guideline. JCO 2020:JCO.19.02757. https:\/\/doi.org\/10.1200\/JCO.19.02757.","DOI":"10.1200\/JOP.19.00699"},{"key":"10.1016\/j.urology.2022.08.035_bib0012","unstructured":"NCCN. National Comprehensive Cancer Network. Prostate Cancer (v. 4.2022). n.d. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf. Accessed July 15, 2022)."},{"key":"10.1016\/j.urology.2022.08.035_bib0013","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2967\/jnumed.120.242180","article-title":"Impact of 68Ga-PSMA-11 PET on the management of recurrent prostate cancer in a prospective single-arm clinical trial","volume":"61","author":"Fendler","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urology.2022.08.035_bib0014","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0015","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1158\/1078-0432.CCR-20-4573","article-title":"Diagnostic performance of 18F-DCFPyL-PET\/CT in men with biochemically recurrent prostate cancer: results from the CONDOR Phase III, multicenter study","volume":"27","author":"Morris","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2022.08.035_bib0016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bju.13792","article-title":"Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study","volume":"120","author":"Jackson","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2022.08.035_bib0017","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.6_suppl.194","article-title":"Dose-intensified versus conventional dose-salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: Six-year outcomes of the SAKK 09\/10 randomized phase III trial","volume":"39","author":"Ghadjar","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.urology.2022.08.035_bib0018","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.ijrobp.2018.08.052","article-title":"Short term androgen deprivation therapy without or with pelvic lymph node treatment added to prostate bed only salvage radiotherapy: the NRG oncology\/RTOG 0534 SPPORT trial","volume":"102","author":"Pollack","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2022.08.035_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2967\/jnumed.118.212563","article-title":"Outcome after PSMA PET\/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis","volume":"60","author":"Schmidt-Hegemann","year":"2019","journal-title":"J Nucl Med."},{"key":"10.1016\/j.urology.2022.08.035_bib0020","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.6_suppl.30","article-title":"Impact of PSMA PET\/CT on SRT planning: preliminary results from the randomized phase III trial NCT03582774","volume":"39","author":"Calais","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.urology.2022.08.035_bib0021","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3389\/fonc.2021.715020","article-title":"Feasibility and outcome of PSMA-PET-based dose-escalated salvage radiotherapy versus conventional salvage radiotherapy for patients with recurrent prostate cancer","volume":"11","author":"Vogel","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0022","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2017.10.022","article-title":"Delineating sites of failure following post-prostatectomy radiation treatment using 68Ga-PSMA-PET","volume":"126","author":"Byrne","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13014-020-01733-x","article-title":"Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques","volume":"16","author":"Rowe","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101242","article-title":"68Ga-PSMA-HBED-CC PET\/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study","volume":"15","author":"Martinez","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0025","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.118.222885","article-title":"Bridging the imaging gap: PSMA PET\/CT has a high impact on treatment planning in prostate cancer patients with biochemical recurrence-a narrative review of the literature","volume":"60","author":"Ekmekcioglu","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urology.2022.08.035_bib0026","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2967\/jnumed.117.192476","article-title":"Impact of 68Ga-PSMA-11 PET on management in patients with biochemically recurrent prostate cancer","volume":"58","author":"Hope","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urology.2022.08.035_bib0027","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.euo.2021.02.003","article-title":"Positron emission tomography and whole-body magnetic resonance imaging for metastasis-directed therapy in hormone-sensitive oligometastatic prostate cancer after primary radical treatment: a systematic review","volume":"4","author":"Farolfi","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0028","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12885-020-06883-5","article-title":"Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy","volume":"20","author":"Oehus","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urology.2022.08.035_bib0029","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II Trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2022.08.035_bib0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522007798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522007798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:57:24Z","timestamp":1758769044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522007798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"alternative-id":["S0090429522007798"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.08.035","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}